Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Corticosteroid Treatment Improves Adult Sepsis Outcomes

By HospiMedica International staff writers
Posted on 23 Jan 2019
A new study concludes that administration of corticosteroids to patients with sepsis is associated with significant improvement in health care outcomes and reduced mortality.

Researchers at Sichuan University (Chengdu, China), Southwest Hospital of Army Medical University (Chongqing, China), and other institutions conducted a systematic review and meta-analysis of studies to examine the efficacy and safety of corticosteroids in patients with sepsis. In all, 37 randomized clinical trials (RCTs) that met inclusion criteria were used to compare administration of corticosteroids with placebo or standard supportive care in 9,564 adult patients with sepsis.

The results revealed that corticosteroid use was associated with reduced 28-day mortality, intensive care unit (ICU) mortality, and in-hospital mortality. Corticosteroids were also significantly associated with increased shock reversal at day seven, vasopressor-free days, ICU length of stay, sequential organ failure assessment score at day seven, and time to resolution of shock. But corticosteroid use was also associated with increased risk of hyperglycemia and hypernatremia. The study was published on December 21, 2018, in JAMA Internal Medicine.

“Corticosteroids have been used as adjuvant therapy for sepsis for more than 50 years without hard evidence to guide patient selection. Physicians have used their clinical judgment to decide how to use corticosteroids,” concluded lead author Chao You, MD, of Sichuan University, and colleagues. “These findings appear to indicate that corticosteroids should be prescribed at a low dose and for a long course. Future studies are needed to associate personalized medicine with clinical phenotyping, genotyping, or metabolomics with the treatment of sepsis.”

Sepsis is characterized by a whole-body inflammatory state caused by the immune system's response to a serious infection, most commonly bacteria, but also fungi, viruses, and parasites in the blood, urinary tract, lungs, skin, or other tissues. Symptoms of sepsis include those related to a specific infection, and are usually accompanied by high fevers, hot, flushed skin, elevated heart rate, hyperventilation, altered mental status, swelling, and low blood pressure. Sepsis causes millions of deaths globally each year.

Related Links:
Sichuan University
Southwest Hospital of Army Medical University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Transportation Stretcher
ES709
New
A4 Medical Color Printer
UP-DR80MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.